pipobroman has been researched along with Abnormalities, Autosome in 2 studies
Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernasconi, P | 1 |
Boni, M | 1 |
Cavigliano, PM | 1 |
Calatroni, S | 1 |
Brusamolino, E | 1 |
Passamonti, F | 1 |
Volpe, G | 1 |
Pistorio, A | 1 |
Giardini, I | 1 |
Rocca, B | 1 |
Caresana, M | 1 |
Lazzarino, M | 1 |
Bernasconi, C | 1 |
Tefferi, A | 1 |
2 other studies available for pipobroman and Abnormalities, Autosome
Article | Year |
---|---|
Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chromosome Aberrations; Female; Humans; H | 2002 |
Is hydroxyurea leukemogenic in essential thrombocythemia?
Topics: Acute Disease; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Chromosome Aberrations; Chr | 1998 |